Tomás Ahern

1.2k total citations
24 papers, 675 citations indexed

About

Tomás Ahern is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Molecular Biology. According to data from OpenAlex, Tomás Ahern has authored 24 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Tomás Ahern's work include Hormonal and reproductive studies (6 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Antifungal resistance and susceptibility (3 papers). Tomás Ahern is often cited by papers focused on Hormonal and reproductive studies (6 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Antifungal resistance and susceptibility (3 papers). Tomás Ahern collaborates with scholars based in Ireland, United Kingdom and Estonia. Tomás Ahern's co-authors include Donal O’Shea, Brian Kirby, Anne‐Marie Tobin, Frederick C. W. Wu, M. Corrigan, Andrew E. Hogan, Cheryl Sweeney, Brian Keevil, Ilpo Huhtaniemi and György Bártfai and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetologia.

In The Last Decade

Tomás Ahern

23 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás Ahern Ireland 13 374 157 138 117 97 24 675
Michael J. Diver United Kingdom 11 748 2.0× 208 1.3× 46 0.3× 202 1.7× 152 1.6× 18 1.1k
Bekir Sami Uyanık Türkiye 15 144 0.4× 84 0.5× 114 0.8× 43 0.4× 40 0.4× 41 691
Earn H Gan United Kingdom 15 562 1.5× 108 0.7× 67 0.5× 43 0.4× 30 0.3× 32 874
J. HARRINGTON CALKINS United States 12 432 1.2× 228 1.5× 176 1.3× 42 0.4× 358 3.7× 15 926
Karine Blouin Canada 14 487 1.3× 184 1.2× 26 0.2× 139 1.2× 127 1.3× 28 1.0k
A Böttner Germany 16 319 0.9× 150 1.0× 54 0.4× 45 0.4× 58 0.6× 31 1.4k
Mark Stene United States 16 598 1.6× 306 1.9× 79 0.6× 20 0.2× 349 3.6× 23 1.2k
Erini Dermitzaki Greece 10 149 0.4× 101 0.6× 115 0.8× 32 0.3× 20 0.2× 10 620
Kathleen E. Bethin United States 12 627 1.7× 127 0.8× 173 1.3× 34 0.3× 25 0.3× 24 1.2k
Anne Kirstine Bang Denmark 17 170 0.5× 251 1.6× 30 0.2× 87 0.7× 460 4.7× 32 932

Countries citing papers authored by Tomás Ahern

Since Specialization
Citations

This map shows the geographic impact of Tomás Ahern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás Ahern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás Ahern more than expected).

Fields of papers citing papers by Tomás Ahern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás Ahern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás Ahern. The network helps show where Tomás Ahern may publish in the future.

Co-authorship network of co-authors of Tomás Ahern

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás Ahern. A scholar is included among the top collaborators of Tomás Ahern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás Ahern. Tomás Ahern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stevenson, David K., Ronald J. Wong, Jonathan D. Reiss, et al.. (2025). A clinician’s musings on oxygen: Too little or too much with life in the balance. Journal of Perinatology. 45(11). 1649–1652.
2.
Ahern, Tomás, et al.. (2021). Generalist vs specialist acute medical admissions - What is the impact of moving towards acute medical subspecialty admissions on efficacy of care provision?. European Journal of Internal Medicine. 98. 47–52. 3 indexed citations
3.
Lynch, Maeve, Anna Malara, Sebastian Vencken, et al.. (2021). Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial. Dermatology. 238(1). 140–147. 8 indexed citations
4.
Ahern, Tomás, Helen O’Brien, Tidi Hassan, et al.. (2019). Sleep duration and physical function in people with severe obesity: a prospective cross-sectional study. Irish Journal of Medical Science (1971 -). 189(2). 517–523. 3 indexed citations
5.
Lynch, Maeve, Anna Malara, Tomás Ahern, et al.. (2019). Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled Trial. Dermatology. 237(1). 66–69. 7 indexed citations
6.
Ho, Jan Hoong, Safwaan Adam, Shazli Azmi, et al.. (2019). Male sexual dysfunction in obesity: The role of sex hormones and small fibre neuropathy. PLoS ONE. 14(9). e0221992–e0221992. 18 indexed citations
7.
Lynch, Maeve, Tomás Ahern, Cheryl Sweeney, et al.. (2017). Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction. International Journal of Dermatology. 56(11). 1103–1118. 48 indexed citations
8.
Antonio, Leen, Frederick C. W. Wu, Terence W O’Neill, et al.. (2016). Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. The Journal of Clinical Endocrinology & Metabolism. 101(7). 2647–2657. 124 indexed citations
9.
Lynch, Maeve, Tomás Ahern, Cheryl Sweeney, et al.. (2016). Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial. Trials. 17(1). 29–29. 13 indexed citations
10.
Ahern, Tomás & Frederick C. W. Wu. (2015). New horizons in testosterone and the ageing male. Age and Ageing. 44(2). 188–195. 17 indexed citations
11.
Rastrelli, Giulia, Tomás Ahern, Joseph D. Finn, et al.. (2015). Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS. The Journal of Clinical Endocrinology & Metabolism. 100(8). 3172–3182. 96 indexed citations
12.
13.
14.
Ahern, Tomás, et al.. (2014). Obesity-related chronic lymphoedema-like swelling and physical function. QJM. 108(3). 183–187. 16 indexed citations
15.
Tobin, Anne‐Marie, Tomás Ahern, Sarah Rogers, et al.. (2013). The dermatological consequences of obesity. International Journal of Dermatology. 52(8). 927–932. 21 indexed citations
16.
Ahern, Tomás, Anne‐Marie Tobin, M. Corrigan, et al.. (2012). Glucagon‐like peptide‐1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study. Journal of the European Academy of Dermatology and Venereology. 27(11). 1440–1443. 55 indexed citations
17.
Ahern, Tomás, Kirsten Doherty, Patricia Fitzpatrick, et al.. (2012). Body mass index estimation and measurement by healthcare professionals. Open Journal of Preventive Medicine. 2(3). 265–271. 6 indexed citations
18.
Hogan, Andrew E., Anne‐Marie Tobin, Tomás Ahern, et al.. (2011). Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia. 54(11). 2745–2754. 131 indexed citations
19.
Ahern, Tomás & Frances J. Hayes. (2010). Risk of hypogonadism in male survivors of childhood cancer. Nature Reviews Endocrinology. 6(3). 129–130. 1 indexed citations
20.
Ahern, Tomás, et al.. (2007). Selective intra-arterial calcium stimulation with hepatic venous sampling in investigation of hyperinsulinemic hypoglycemia. Endocrine Abstracts. 14. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Diver Breakdown of academic impact, for papers by Bekir Sami Uyanık Breakdown of academic impact, for papers by Earn H Gan Breakdown of academic impact, for papers by J. HARRINGTON CALKINS Breakdown of academic impact, for papers by Karine Blouin Breakdown of academic impact, for papers by A Böttner Breakdown of academic impact, for papers by Mark Stene Breakdown of academic impact, for papers by Erini Dermitzaki Breakdown of academic impact, for papers by Kathleen E. Bethin Breakdown of academic impact, for papers by Anne Kirstine Bang
Rankless by CCL
2026